RecruitingNot ApplicableNCT06833450

Reliability of IUS in Crohn's Disease

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

30 participants

Start Date

Jan 19, 2022

Study Type

INTERVENTIONAL

Conditions

Crohn Disease (CD)

Summary

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is assessing the reliability of intestinal ultrasound (IUS) — a non-invasive imaging test using sound waves to look at the intestines — in patients with Crohn's disease. The goal is to understand how consistently this technique works across different operators and settings, which could help establish it as a standard monitoring tool. **You may be eligible if...** - You have been diagnosed with Crohn's disease for at least 1 month - You are 18 years or older - You have French national health insurance coverage - You are able to provide written informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are a minor (under 18) - You are under legal guardianship or supervision, or your freedom is restricted by administrative or judicial order Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.